Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06643351 · ClinicalTrials.gov registry record · NA
Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia
A NA study of Gestational Diabetes Mellitus in Pregnancy and Neonatal Hypoglycemia, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 218
- Enrollment target
- 1
- Study location
NCT06643351: Recruiting NA study of Gestational Diabetes Mellitus in Pregnancy and Neonatal Hypoglycemia, sponsored by University of Pittsburgh.
NCT06643351 is a NA study of Gestational Diabetes Mellitus in Pregnancy and Neonatal Hypoglycemia that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 218 participants, below the 1,852-participant average among 9 other Gestational Diabetes Mellitus in Pregnancy trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06643351, a NA study of Gestational Diabetes Mellitus in Pregnancy and Neonatal Hypoglycemia, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 218 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess whether a liberal intrapartum glycemic target range compared to usual care standard control ranges will lead to a decrease in the rate of neonatal hypoglycemia among pregnant patients in labor with diabetes.
Primary Outcome
Number of newborns with neonatal hypoglycemia, defined as a blood glucose of less than 45mg/dL
Conditions Studied
Interventions
- OTHER Standard Intrapartum Glucose Target Range
- OTHER Liberalized Intrapartum Glucose Target Range
Study Locations (1)
Pennsylvania
- Magee-Women's Hospital of UPMC - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2024-12-03 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT06643351 shows while recruiting
NCT06643351 is an interventional study that assigns participants to a tested intervention. The registered 218 participants enrollment target is mid-sized for trials with a published cap, below the 1,852-participant average among 9 other Gestational Diabetes Mellitus in Pregnancy trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Gestational Diabetes Mellitus in Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Standard Intrapartum Glucose Target Range is the first listed.
NCT06643351 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06643351 about?
NCT06643351 is a clinical study titled "Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia". The purpose of this study is to assess whether a liberal intrapartum glycemic target range compared to usual care standard control ranges will lead to a decrease in the rate of neonatal hypoglycemia among pregnant patients in labor with diabetes.
What is the current status of trial NCT06643351?
This trial is currently recruiting. It is a NA study. The enrollment target is 218 participants. The study started on 2024-12-03. Estimated completion is 2026-06.
What conditions does trial NCT06643351 study?
This clinical trial studies the following conditions: Gestational Diabetes Mellitus in Pregnancy, Neonatal Hypoglycemia, Pregestational Diabetes Mellitus.
What interventions are being tested in trial NCT06643351?
The interventions under investigation include: Standard Intrapartum Glucose Target Range (OTHER), Liberalized Intrapartum Glucose Target Range (OTHER).
Who is sponsoring clinical trial NCT06643351?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06643351 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes Mellitus in Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06643351's enrollment target sits among peer trials
218 4th of 9 higher than 6 of 9 other Gestational Diabetes Mellitus in Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gestational Diabetes Mellitus in Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of a Non-nutritive Sweetener Reduction Intervention in Pregnancy and Lactation on Maternal and Infant Outcomes
RECRUITING · NA
-
Early Detection of Gestational Diabetes Mellitus in Pregnancy
RECRUITING · NA
-
CGM for the Early Detection and Management of Hyperglycemia in Pregnancy
RECRUITING · NA
-
Mobile App Logging for Diabetes in Pregnancy
RECRUITING · NA
-
Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial
RECRUITING · NA
-
The CGMS in GDM Labor and Delivery Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04693858 · 218 participants · NA
Efficacy Trial of the CALM Intervention
- NCT05909202 · 218 participants · NA
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
- NCT06000761 · 218 participants · NA
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
- NCT06249126 · 218 participants · NA
Primary Subtalar Arthrodesis for Calcaneal Fractures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI